|
Market Closed -
Nasdaq
16:00:00 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 2.260 USD | +3.20% |
|
-4.24% | +38.65% |
| 10-06 | Guggenheim Initiates Ovid Therapeutics at Buy | MT |
| 09-20 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OVID THERAPEUTICS INC. | Bio Therapeutic Drugs | +3.20% | -4.24% | +38.65% | +29.14% | -37.91% | 428M |  | |  |
- Stock Market
- Stocks
- OVID Stock
- Charts Ovid Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
